Atrial Fibrillation and Flutter Clinical Trial
Official title:
Versatility of a Circular Multielectrode Catheter in the Individualized Recognition & Treatment of Atrial Fibrillation and Related Arrhythmias Using Pulsed Field Energy
The purpose of this pragmatic study is to evaluate the safety, performance and effectiveness of the VARIPULSE catheter technology used in combination with the TRUPULSEā¢ Generator, and the compatible EAM system (Carto 3D) to treat patients with atrial fibrillation and related arrhythmias during clinically-indicated ablation procedures.
By virtue of its efficiency, safety profile, and potential for improved efficacy in certain patient populations (e.g., thickened atrial tissue of hypertrophic cardiomyopathy (HCM) patients), there is tremendous excitement about the role of pulsed field ablation (PFA) to treat atrial fibrillation and related arrhythmias. However, most PFA clinical trials enroll very selected populations and have highly focused inclusion/exclusion criteria - for example, typically only paroxysmal or persistent atrial fibrillation (AF) patients with upper age criteria are included, other disease states such as HCM are excluded, and typically redo ablation procedures are also excluded. The latter is particularly problematic since redo procedures are quite prevalent in most physicians' clinical practice. In some sense, the incorporation of these restrictive criteria is not terribly surprising since most of the novel PFA catheters are specifically designed to perform only certain aspects of the AF ablation procedure (e.g., just PVI). That is, when there are more complex substrates (where other types of lesion sets may be needed), it may not be practical to allow a more inclusive criteria for enrollment. Of course, the downside is that the majority of the patients that are eventually treated in clinical practice are not reflected by the enrolled patient population. The VARIPULSEā¢ catheter technology is a novel circular catheter with a variable loop design, containing multiple electrodes with individual irrigation pores capable of delivering pulse-field energy. The Ablation procedure will follow the below sequence: - Anatomical and voltage mapping of the left and/or right atrium - To perform this mapping, the VARIPULSE bi-directional catheter or a compatible conventional FDA-approved multi-electrode mapping catheter (e.g., Pentaray, Octaray or Optrell) may be used - Activation mapping of any-presenting or inducible atrial flutter - Pulmonary Vein Isolation (PVI) to be achieved in all patients with atrial fibrillation (if not already achieved). - Confirmation of entrance block with adenosine or isoproterenol challenge - Additional ablation lesion sets are per the investigator's discretion including: - Posterior wall Isolation - Regional fractionation clusters - Cavo-tricuspid isthmus Line - Mitral Isthmus Line - Any micro-/macro-reentrant atrial tachycardia's - As part of the ablation procedure, any safety assessments that are considered important (e.g., EGD, coronary angiography, etc.) may be performed; these data will also be collected. This study is a prospective, single-center, non-randomized, interventional clinical study to determine the safety and efficacy in using BWI IRE ablation system in a variety of atrial arrhythmias. Subjects will be followed for 12 months post-procedure. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03862859 -
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
|
Phase 4 | |
Completed |
NCT03788044 -
Effect of Targeted Education for Atrial Fibrillation Patients (Application Substudy)
|
N/A | |
Completed |
NCT03707873 -
Effect of Targeted Education for Atrial Fibrillation Patients
|
N/A | |
Active, not recruiting |
NCT05009225 -
Clinical Decision Support for Atrial Fibrillation and Flutter
|
||
Recruiting |
NCT02623049 -
Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation
|
||
Completed |
NCT05509517 -
A Clinical Trial of the Use of Remote Heart Rhythm Monitoring With a Smartphone After Cardiac Surgery
|
N/A | |
Completed |
NCT03377465 -
Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis
|
N/A | |
Completed |
NCT03243604 -
cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study
|
||
Enrolling by invitation |
NCT06452823 -
Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization
|
||
Recruiting |
NCT04855890 -
HIgh Power Short Duration Radiofrequency Ablation or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation
|
N/A | |
Active, not recruiting |
NCT03110627 -
Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead
|
N/A | |
Completed |
NCT03911986 -
Risk-Based Screening for the Evaluation of Atrial Fibrillation Trial
|
N/A | |
Completed |
NCT03472495 -
Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial
|
Phase 4 | |
Recruiting |
NCT04438395 -
Dielectric Tissue Imaging in Cavotricuspid Isthmus Ablation
|
||
Completed |
NCT02344901 -
ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES)
|
N/A | |
Completed |
NCT02273609 -
INR Control and Atrial Fibrillation in Primary Care in Spain (PAULA)
|
N/A | |
Recruiting |
NCT05159180 -
Development of a New Impedance Mapping System for Ablation of Atrial Arrhythmias in Patients
|
||
Recruiting |
NCT06187155 -
Impact of Education Level on Clinical Outcomes in Self-INR Managed Patients
|
N/A | |
Active, not recruiting |
NCT03488420 -
Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE
|
||
Completed |
NCT05008601 -
Aino ECG Ambulatory Study
|